May 2010

 

 

From the editors of CCH Federal Securities Law Reporter, CCH Blue Sky Law Reporter and the securities publications of Aspen Publishers, this update describes important developments covered in these publications, as well as timely topics of interest generally to federal and state securities practitioners. Also included is a “Hot Topic of the Month,” with research tips and references to CCH and Aspen source material on point. Finally, this update includes a preview of IPO Vital Signs, an advanced IPO research analysis tool, for IPO professionals and pre-IPO companies.

 

To view past issues of the Securities Update, please visit http://business.cch.com/updates/securities.

 

If you have questions or comments concerning the information provided below, please contact me at rodney.tonkovic@wolterskluwer.com.

 

 

Financial Crisis Resources

 

 

 

 

CCH Federal Securities Law Reporter

 

 

SEC Proposes Significant Revisions to Asset-Backed Securities Offerings.  The SEC approved the issuance of a proposal that would significantly revise Regulation AB and other rules relating to the offering process and disclosure and reporting practices for asset-backed securities. The proposed rules would better inform investors about asset-backed securities by requiring the disclosure of standardized information about the loans in the pool with computer-readable data tags. The loan level information would be provided when an asset is securitized, and additional information would be provided on an ongoing basis. Issuers of asset-backed securities would file a computer program that allows investors to analyze information about the loans within the pool of assets on the SEC's Web site. The program would provide information about how the loan payments are distributed to investors, how losses or the lack of payment on the loans will be divided among investors and when administrative fees are paid to service providers. Investors also would be given more time to consider the information before making an investment decision. The proposal would also require the sponsor to hold five percent of each class of asset-backed securities and not to hedge those holdings and would require additional information about originators and sponsors. Release No. 33-9117 is reported at ¶88,891 (IntelliConnect) (IRN) (ip access user).

 

New Large Trader Reporting System Proposed. The SEC approved a proposal that would establish a large trader reporting system to allow the agency to identify and monitor the activities of significant market participants. Large traders would be identified as those whose transactions in exchange listed securities equal or exceed two million shares or $20 million during any calendar day, or 20 million shares or $200 million during any calendar month. These traders would be assigned an identification number to be used by their broker-dealers to maintain and report trade data. The proposal calls for the filing of a new form under Exchange Act Section 13(h) on which large traders would identify themselves based on the transactions criteria. The unique identification numbers would enable the SEC to reconstruct market activity, analyze trading data and investigate potentially manipulative, abusive or other illegal trading activity. Release No. 34-61908 is reported at ¶89,003 (IntelliConnect) (IRN) (ip access user).

 

SEC Proposes Amendments to Improve Access to Listed Options. The SEC approved the issuance of a proposal to amend Regulation NMS Rule 610 to extend its scope and apply its anti-discrimination requirement to the options markets. The rule would prohibit an options exchange from unfairly impeding access to the quotation it displays and would limit the fees an options exchange can charge investors and others who wish to access a quote on the exchange. Release No. 34-61902 is reported at ¶89,002 (IntelliConnect) (IRN) (ip access user).

 

Unanimous Supreme Court Allows Vioxx Suit to Proceed. A unanimous Supreme Court held that the limitations period for securities fraud cases begins to run on the earlier of 1) the date on which the plaintiff actually discovered the facts constituting the violation or 2) the date on which a reasonably diligent plaintiff would have made that discovery. In securities fraud cases, held the court, facts showing scienter are among those that constitute the violation.

In this case, an investor class sued Merck & Co., alleging that the drug maker knowingly misrepresented the risks associated with Vioxx, an arthritis medication. A study showed adverse cardiovascular results for Vioxx when compared to naproxen, another pain reliever. Merck suggested that this might be due to the absence of a benefit conferred by naproxen rather than a harm caused by Vioxx. The investors alleged that Merck committed fraud by promoting the so-called "naproxen hypothesis" even though it knew the hypothesis was false.

Writing for the court, Justice Breyer noted that securities fraud plaintiffs must show that it is more likely than not that the defendant acted with the relevant knowledge or intent to state a claim. In these cases, stated Justice Breyer, it would "frustrate the very purpose of the discovery rule" in the Sarbanes-Oxley Act limitations provision if the limitations period began to run regardless of whether a plaintiff had discovered any facts suggesting scienter. "So long as a defendant concealed for two years that he made a misstatement with an intent to deceive," wrote the court, "the limitations period would expire before the plaintiff had actually "discover[ed]" the fraud." In applying this standard, the court concluded that an FDA warning letter to Merck which stated that the company had "minimized" a study's "potentially serious cardiovascular findings," and the pleadings filed in products-liability actions alleging that Merck had "omitted, suppressed, or concealed material facts" concerning Vioxx, were insufficient to initiate the limitations period. The FDA letter and the complaints did not contain any specific information concerning the alleged deceptive promotion of the naproxen hypothesis, concluded the court. Merck & Co., Inc. v. Reynolds (U.S. Sup Ct) will be published in a forthcoming Report.

 

3rd Circuit Rejects Liability Theories in CFO's Criminal Trial. In ruling on a pre-trial interlocutory appeal, a 3rd Circuit panel rejected the legal theories underlying several criminal fraud charges against the former chief financial officer of Bristol-Myers Squibb. The court also found that the trial judge properly excluded testimony from a government expert witness. The case will, however, go forward on charges based on other misstatements and omissions, conspiracy, aiding and abetting and other counts. The charges arose from statements made by Frederick Schiff, the former CFO, concerning Bristol-Myers' inventory backlog. As alleged, Mr. Schiff and others offered incentives to their wholesalers to carry larger than normal inventories to conceal the negative impact that the backlog would have on future sales. The officers then allegedly made material misstatements and omitted material facts concerning the inventory situation in analyst calls.

With regard to the claimed omissions, the 3rd Circuit initially held that Mr. Schiff had no fiduciary duty to rectify the allegedly material misstatements made by another executive during the analyst calls. The panel referred to the 3rd Circuit's 2000 decision in Oran v. Stafford (2000-01 CCH Dec. ¶91,205), where the court determined that a duty to disclose existed when there is 1) insider trading, 2) a statute requiring disclosure or 3) an inaccurate, incomplete or misleading prior disclosure. The government argued that Mr. Schiff's duty to disclose arose from a general fiduciary obligation owed by "high corporate executives" to the company's shareholders. The court rejected the government's argument that the Oran factors were not an exclusive list, and that this fiduciary duty qualified as a fourth circumstance. Stating that "such a generalized corporate fiduciary duty has few logical boundaries," the court found the government's position too broad and vague to support an extension of the Oran holding. The panel also rejected the government's claim that Mr. Schiff should have made corrective disclosures in the company's Form 10-Q filing concerning his statements in the analyst calls. Because the government stipulated that Mr. Schiff was not charged with affirmative misstatements in the company's SEC filings, the alleged omissions were not tied to any purported misleading statements in those filings.

Finally, the court held that the trial judge properly excluded proffered expert testimony from a government witness. The government sought to present an expert to testify on materiality and the company's stock price drop following the disclosures, but the appeals panel found that the expert's evidence was not sufficiently tied to the facts of the case and would not aid the jury in resolving factual disputes. The appellate court noted, however, that the trial judge stated that if the government properly laid the foundation for the expert's testimony at trial, then the prosecution could make a renewed application to the court to present the stock price drop through the expert as evidence of materiality. U.S. v. Schiff (3rdCir) is reported at ¶95,715 (IntelliConnect) (IRN) (ip access user).

 

Group Pleading Doctrine Not Substantive Ground for Fraud Liability. In an SEC enforcement action, a district court (SD NY) denied in part motions to dismiss claims brought by the Commission against former officers and directors of an Internet portal that targeted Spanish and Portuguese-speaking markets. According to the complaint, the company improperly recognized revenue earned through base book, incremental revenue, and contingent transactions by two of its subsidiaries in order to meet its revenue projections and consequently made misleading statements in SEC filings, as well as to external auditors and potential investors. The SEC alleged that the executives aided and abetted the company's violations of the antifraud and recordkeeping provisions of the securities laws. The court had previously dismissed all of the SEC's claims against two board members and some of the claims against two officers, but the SEC was granted leave to replead and did so.

The court first found that the complaint alleged with sufficient particularity that the directors made material misstatements. According to the court, the complaint provided enough detail to give the directors fair notice of the conduct with which they were charged. The complaint, however, was vague regarding the role of a company officer and failed to plead with the required particularity that the officer was liable for the misstatements. Next, the court found that the Commission properly pleaded that the directors acted with scienter but failed as to the officer. The Commission successfully alleged that the directors knew or should have known that disclosures misstated the amount of the company's barter revenue and thus misstated the percentage of revenue attributable to barter transactions. The allegations regarding the officer, however, were conclusory and accordingly dismissed.

The court then turned to the aiding and abetting claims and found that the Commission alleged that the officer had aided and abetted the company's primary violations because she had actively participated in contingent transactions and knew that services that were given away were recorded as revenue. The complaint then successfully alleged that the officers and directors aided and abetted the company's violations of the recordkeeping provisions of the securities laws because they were sufficient to show that the executives substantially assisted the company in its improper recordkeeping and revenue reporting. Finally, the complaint adequately alleged that the executives caused the company's books and records to be falsified and that a director had made false statements to auditors.

In a related action, a company officer's motion for summary judgment was granted. The officer, according to the complaint, did not report an oral contingency to the company's finance department, thus causing it to be inaccurately recorded as revenue. The officer argued that the Commission offered no facts to support its claims. The court agreed, stating that the SEC seemed to believe that the group pleading doctrine freed it of the requirement to link the officer to the making of a misstatement. In other words, the doctrine is only a pleading device, not a substantive ground for fraud liability. Moreover, the Commission actually conceded at oral argument that it could not prove that the officer bore personal responsibility for the misstatements. SEC v. Espuelas (SD NY) is reported at¶95,656 (IntelliConnect) (IRN) (ip access user)  and ¶95,657 (IntelliConnect) (IRN) (ip access user).

 

 

CCH Blue Sky Law Reporter  

 

Connecticut Revises Electronic Form D Filing Requirement. The electronic Form D filing requirement for offerings made in reliance on SEC Rules 504, 505 and 506 was revised by the Connecticut Department of Banking to no longer require submitting SEC-filed Form D amendments to the Department because the amended filings can be viewed online. ¶14,622 (IntelliConnect) (IRN) (ip access user).

 

Michigan's Fourth Transition Order Acknowledges SEC Form D Built-In Consent to Service of Process. The fourth transition order released by the Michigan Office of Financial and Insurance Regulation following adoption of the 2009 Michigan Uniform Securities Act no longer requires Form D issuers to file a separate consent to service of process; the designated consent to service of process built into new Form D meets the service of process requirement when new Form D is filed in Michigan. ¶32,666 (IntelliConnect) (IRN) (ip access user).

 

Mississippi Permanently Adopts Temporary Rules to Align with New Act. Temporary rules pertaining to broker-dealers, agents, investment advisers, investment adviser representatives and federal covered investment advisers, and to federal covered securities, registration of securities and exemptions from securities registration, were permanently adopted by the Mississippi Securities Division, effective April 8, 2010, to coordinate with the new Mississippi Uniform Securities Act that took effect on January 1, 2010. Much of the substance of the old rules continues with the temporary rules so that many of the rule amendments are nonsubstantive, updating statutory references to reflect new Act section numbers or changing rule section and subsection nomenclature. Please note that some of the CCH paragraph numbers now attach to different rules than the rules they previously attached to. ¶34,433 (IntelliConnect) (IRN) (ip access user) - ¶34,435 (IntelliConnect) (IRN) (ip access user), ¶34,461 (IntelliConnect) (IRN) (ip access user) - ¶34,469 (IntelliConnect) (IRN) (ip access user), ¶34,522 (IntelliConnect) (IRN) (ip access user) - ¶34,542 (IntelliConnect) (IRN) (ip access user).

 

Nevada Increases Regulation D Rule 505/ 506 Filing Fee. The fee for filing Form D to make an offering under either Rule 505 or 506 of federal Regulation D is increased to $500, from $300. ¶38,501 (IntelliConnect) (IRN) (ip access user).

 

Texas Adopts Preliminary Evaluation of License Eligibility for Persons with Criminal Backgrounds. Persons applying for a broker-dealer, agent, investment adviser or investment adviser representative license in Texas may request a criminal history evaluation letter from the State Securities Board to preliminarily determine the persons' eligibility to receive the license. Persons enrolled (or planning to enroll) in an education program to prepare for an initial license or who plan to take an examination for an initial license and believe they might be ineligible for a license because of a conviction or deferred adjudication for a felony or misdemeanor may request the criminal history evaluation letter. The request must state the basis for the person's potential ineligibility, provide certain specified information, and be accompanied by a $100 fee. ¶55,517F (IntelliConnect) (IRN) (ip access user), ¶55,591E (IntelliConnect) (IRN) (ip access user), ¶55,595E (IntelliConnect) (IRN) (ip access user).

 

New York AG States Claims Against Manager of Madoff Feeder Funds. The Supreme Court of New York (County of New York) has ruled that the state Attorney General successfully stated a claim for securities fraud against a manager of private investment funds who allegedly made material misrepresentations and omissions to investors while blindly feeding the investors' funds into the Ponzi scheme operated by Bernard Madoff. The trial court ruled the Attorney General adequately pleaded that the manager and his firm violated the Martin Act's prohibitions against fraudulent practices by misrepresenting in the offering documents that he would be controlling and actively managing the funds. The complaint also successfully pleaded that the manager omitted material facts significant to a reasonable investor by concealing and failing to disclose the actual role played by Madoff in the funds' investment strategy and operations.

 

Although the defendants argued that any alleged misrepresentations were balanced by cautionary language in the offering memoranda, which provided that investment management duties could be delegated to independent money managers without prior notice or investor consent, the court ruled that the "bespeaks caution" doctrine does not apply to misrepresentations of present or historical facts. Moreover, documentary evidence showing that some investors were aware that monies were invested with Madoff did not bar the Attorney General's claim because the complaint alleged that hundreds of investors were not of this fact. Finally, the defendants' contention that the Attorney General could not show loss causation was rejected because loss causation is not an element of a Martin Act claim. People v. Merkin is reported at ¶74,821 (IntelliConnect) (IRN) (ip access user).

 

 

Aspen Federal Securities Publications  

 

Practicing Under The U.S. Anti-Corruption Laws, by Joseph P. Covington and Iris E. Bennett. This brand new publication is now available on IntelliConnect. Practicing Under The U.S. Anti-Corruption Laws is designed to assist practitioners and company counsel to comply with the Foreign Corrupt Practices Act (FCPA) and all major U.S. anti-corruption laws. It discusses a wide range of issues relevant to counseling and defending companies and individuals with respect to U.S. anti-corruption laws and how they impact the conducting of business in the international marketplace. Covered are such important topics as the FCPA’s anti-bribery, books and records, and internal controls provision; federal money laundering laws; other federal statutes, such as the wire and mail fraud statutes, the Travel Act, and certain U.S. sanctions programs; the Sarbanes-Oxley Act and other securities laws and regulations; corporate criminal liability in the FCPA context; DOJ and SEC enforcement; special issues faced by U.S. government contractors; FCPA compliance and prevention including many practical tips on how to have an effective program in this area; fundamentals of conducting internal investigations; dealing with a government investigation and privilege issues; and global anti-corruption efforts.

 

 

Hot Topic of the Month

 

This month’s hot topic is margin transactions. Margin transactions involve speculation in securities with borrowed money. Section 7 of the Exchange Act imposes margin controls designed to prevent excessive use of credit for the purchase or carrying of securities. In enacting these controls, Congress intended to reduce the aggregate amount of credit resources devoted to market speculation and to achieve a more balanced use of such resources in commerce, industry, and agriculture.

 

Under Section 7(a), the Federal Reserve Board has authority to impose margin standards on certain persons for securities other than exempted securities. The standards thus prescribed by the Board apply to: broker-dealers and national securities exchange members (Regulation T); banks and nonbank lenders (Regulation U); and borrowers (Regulation X).

 

The Federal Reserve Board's duties under the Exchange Act relate chiefly to the determination of margin to be required on security loans, and the SEC has responsibility to enforce the Board's determinations. There is no private cause of action under Exchange Act Section 7 and the accompanying regulations. As the Second Circuit reasoned in Bennett v. United States Trust Co. of New York (CA-2 1985), there is no evidence that Congress intended to create such a private cause of action. Moreover, Congress did not enact Section 7 for the special benefit of investors. Although the protection of individuals was an incidental purpose, the primary objective was to protect the overall economy from excessive speculation. Finally, recognizing a private cause of action would undermine the purposes behind Section 7.

 

We publish information in a wide range of resources (e.g., Federal Securities Law Reporter, SEC Today, Securities Regulation - Loss & Seligman, etc.), and document types (cases, laws, regulations, newsletter articles, treatise discussion). For example:

 

  • Federal Securities Law Reporter

o         Exchange Act Section 7(a) at ¶22,001 (IntelliConnect) (IRN) (ip access user)

o         Regulation T at ¶22,251, et seq. (IntelliConnect) (IRN) (ip access user)

o         Regulation U at ¶22,301, et seq. (IntelliConnect) (IRN) (ip access user)

o         Regulation X at ¶22,351, et seq. (IntelliConnect) (IRN) (ip access user)

o         Bennett v. United States Trust Co. of New York (CA-2 1985) at ¶92,250 (IntelliConnect) (IRN) (ip access user)

o         CCH Explanations (e.g., ¶22,011 (IntelliConnect) (IRN) (ip access user))

·         SEC Today

o         House Passes Securities Act of 2008 Enhancing SEC Enforcement Powers (9-12-08) (IntelliConnect) (IRN) (ip access user)

·         Securities Regulation – Loss & Seligman (e.g., Chapter 8.B.4 (IntelliConnect) (IRN) (ip access user))

·         SEC Answer Book – Johnson & McLaughlin (e.g., § 3.08 (IntelliConnect) (IRN) (ip access user))

·         Jim Hamilton’s World of Securities Regulation

 

IPO Vital Signs

 

IPO Vital Signs, an advanced IPO research analysis tool, assists IPO professionals and pre-IPO companies satisfy their most challenging research needs and answers hundreds of mission critical questions for all the players in the IPO process. IPO Vital Signs tabular data analyses focus on issues surrounding client advisement, deal negotiation, and prospectus disclosure.

 

IPO Week in Review, a weekly e-newsletter to keep professionals up to date with recent filing and going public activity, is an important element of the IPO Vital Signs system or is available by separate subscription. Coverage includes a monthly feature article on recent trends in going public in the U.S.

 

To see how an IPO Vital Sign works click on the Vital Sign title below:

 

 

 

 

 


 

#324 – SIC Codes

Use IPO Vital Sign #324 to…

·         Review the number and percentage of companies going public in each SIC Code

·         Analyze trends over time

and drill down into the different SIC Codes to see

·         IPO issuers’ company names and business descriptions

·         Review “Prospectus Summary” first paragraphs (Final Prospectus business descriptions)

·         Issuers’ headquarters by country and state

·         Offer amounts

·         Offer dates

 

 

Tip! Click on blue numbers to drill down for more information.

Select a number of issuers’ final prospectus business descriptions by clicking in boxes of those you wish to review in the third column (placing a check-mark in each box), and clicking the [COMPARE] button at the top of the fourth column.